Discussing the lack of diversity in the psychedelics space with Jennifer Montjoy.
Similar Posts
Interview with Sam Chapman, Executive Director of the Healing Advocacy Fund
This week on the Psychedelic Spotlight podcast, we talk with Sam Chapman. Sam is a resident of Portland, Oregon, he was the Campaign Manager for Oregon Measure 109, and is now the Executive Director of the Healing Advocacy Fund, a nonprofit organization dedicated to supporting the nation’s first regulated psilocybin therapy program.
The Narrowing of Psychedelic Discourse
Psychedelic discourse was once filled with visions of infinite possibilities, but recently the conversation has turned to more mundane concerns
Interview with James Lanthier, CEO of Mindset Pharma
In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take the drug to clinical trials, and why next generation drugs are an important commercial opportunity for anyone looking to invest in the psychedelic sector.
Math Over Myth: Psychedelic & Cannabis Ballot Initiative Recap
The 2022 midterm elections featured cannabis and psychedelics decriminalization in many states. Here are the results
Psychedelic Drug Use Among College Students Increased During Covid-19 Pandemic
Annual survey finds college students drank less during the pandemic, in favor of smoking more marijuana and experimenting with hallucinogens.
Interview with Patrick Moher, CEO of Microdose
In this chat, he discusses some of the challenges involved in moving virtual events to an in-person conference (during a pandemic), who and what to expect at the event, and why Wonderland Miami is not just any other conference, but a one-of-a-kind experience.